IMS Health

Drug Prices: Costly Cures
Risk & Compliance

Drug Prices: Costly Cures

An American fight over expensive new treatments has global implications.
By Economist Staff | June 9, 2014
Read More
Not at All Taxing
Corporate Finance

Not at All Taxing

IMS Health's spin-off of Gartner Group breaks new ground in tax avoidance.
By S.L. Mintz | August 1, 1999
Read More
Not At All Taxing
Tax

Not At All Taxing

IMS Health's spin-off of Gartner Group breaks new ground in tax avoidance.
By S.L. Mintz | August 1, 1999
Read More